Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report)’s share price was up 11.9% during mid-day trading on Thursday . The stock traded as high as $2.85 and last traded at $2.82. Approximately 326,018 shares traded hands during mid-day trading, a decline of 82% from the average daily volume of 1,794,341 shares. The stock had […]
Pharmaceutical companies last year launched new U.S. drugs at prices 35% higher than in 2022, reflecting in part the industry's embrace of expensive therapies for rare diseases like muscular dystrophy, a Reuters analysis found. The median annual list price for a new drug was $300,000 in 2023, according to the Reuters analysis of 47 medicines, up from $222,000 a year earlier. In 2021, the median annual price was $180,000 for the 30 drugs first marketed through mid-July, according to a study published in JAMA.
In this article, we will be taking a look at the 20 fastest growing biotech companies in the US. If you are not interested in learning about the landscape of biotech companies, head straight to the 5 Fastest Growing Biotech Companies In The US. The biotechnology sector in the United States is witnessing a surge […]
EAM Investors LLC bought a new stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 335,390 shares of the company’s stock, valued at approximately $1,060,000. EAM Investors LLC owned about 0.18% […]
EAM Investors LLC purchased a new position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) in the third quarter, Holdings Channel.com reports. The fund purchased 335,390 shares of the company’s stock, valued at approximately $1,060,000. Other large investors have also added to or reduced their stakes in the company. Swiss National Bank lifted its […]